Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,259 public trials 1,188 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Not Yet Recruiting

Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

NCT07720167

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States

View Trial Details

Not Yet Recruiting

Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

NCT07718737

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Coffs Harbour Health Campus Coffs Harbour, Australia

Austin Health (Olivia Newton John Cancer Centre) Melbourne, Australia

St Vincent's Hospital Melbourne Melbourne, Australia

Calvary Mater Newcastle Newcastle, Australia

View Trial Details

Not Yet Recruiting

Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors

NCT07551778

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

NCT07718243

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
Locations: The Christie NHS Foundation Trust Manchester, United Kingdom

The Royal Marsden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom

View Trial Details

Not Yet Recruiting

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

NCT07360743

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Institut Bergonie Bordeaux Bordeaux, France

APHP-Hôpital Ambroise Paré Boulogne-Billancourt, France

Centre Antoine Lacassagne Nice, France

Institut Gustave Roussy Villejuif, France

View Trial Details

Not Yet Recruiting

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

NCT07482605

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

NCT07625644

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

NCT07671092

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations: Research Facility Christchurch, New Zealand

View Trial Details

Not Yet Recruiting

In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy

NCT07653438

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

NCT07450183

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Henry Ford Health Detroit, Michigan, United States

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions